Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
VYNE Therapeutics Inc. (MNLO)
|
|
Operating Efficiency |
|
|
|
|
Annual |
|
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Source | Source | Source | Source | Source | Source | Source | Source |
Turnover Ratios |
Inventory turnover | | 0.0 | 0.3 | 0.0 | | | | |
Asset turnover | 0.0 | 0.0 | 0.2 | 0.0 | 0.0 | 0.1 | | |
|
Returns on Capital |
ROIC (excluding intangibles) | -421.0% | -265.4% | -1452.4% | -204.5% | -113.3% | -70.7% | | |
ROIC (including intangibles) | -747.3% | -327.1% | -1157.2% | -932.7% | -90.2% | -60.0% | -41.8% | |
ROE | -110.1% | -79.4% | -533.7% | -544.6% | -57.6% | -56.6% | -48.5% | |
ROA | -84.9% | -57.6% | -213.5% | -117.9% | -53.7% | -44.3% | -34.1% | |
|
Cash Conversion Cycle |
Days sales outstanding | 132.4 | 2,972.9 | 275.0 | 111.2 | 0.0 | 62.6 | 0.0 | |
Days payables outstanding | 3,088.3 | 25,550.0 | 1,253.4 | 392,415.6 | 27,292.0 | | | |
Days inventory outstanding | | | 1,941.4 | 27,496.7 | | | | |
Cash conversion cycle | -2,955.9 | -22,577.1 | 963.1 | -364,807.7 | -27,292.0 | | | |
|